20 Essential Tremor Clinical Trials in Minneapolis, MN (2026)

Q: How do I join a clinical trial in Minneapolis?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Minneapolis research site will contact you.

Recruiting Essential Tremor Studies in Minneapolis

NCT00097292Recruiting

TrialNet Pathway to Prevention of T1D

Rationale: The accrual of data from the laboratory and from epidemiologic and prevention trials has improved the understanding of the etiology and pathogenesis of type 1 diabetes mellitus (T1DM). Gen...

Minneapolis, MN75,000 participantsUniversity of South Florida

View Study Details

NCT04098445Recruiting

TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients

Hematopoietic stem cell transplant (HSCT) is an effective but toxic therapy and pulmonary morbidity affects as many as 25% of children receiving transplant. Early pulmonary injury includes diffuse alv...

Minneapolis, MN2,000 participantsChildren's Hospital Medical Center, Cincinnati

View Study Details

NCT04665206Recruiting

Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors

This is an open-label, dose escalation and expansion study to evaluate the safety, tolerability, PK, and biological activity of VT3989 administered, alone or in combination, once daily in patients wit...

Minneapolis, MNPHASE1434 participantsVivace Therapeutics, Inc

View Study Details

NCT05797831Recruiting

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who have achieved complete response or partial response on chemotherapy. The ...

Minneapolis, MNPHASE2268 participantsKartos Therapeutics, Inc.

View Study Details

NCT05117255Recruiting

Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity

This project is designed to determine if a computer-delivered cognitive-behavioral treatment can improve the otherwise poor alcohol use disorder treatment outcomes for individuals with a co-occurring ...

Minneapolis, MNNA256 participantsUniversity of Minnesota

View Study Details

NCT07091487Recruiting

Effectiveness of the Diabetes Homeless Medication Support (D-HOMES) Program on Diabetes Management

The goal of this clinical trial is to learn if the Diabetes Homelessness Medication Support (D-HOMES) wellness coaching model is effective for adults who speak English or Spanish, have Type 2 diabetes...

Minneapolis, MNNA256 participantsKatherine Vickery

View Study Details

NCT06217822Recruiting

First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)

Researchers are looking for a better way to treat participants who have metastatic castration-resistant prostate cancer (mCRPC). mCRPC is a cancer of the prostate (male reproductive gland found below...

Minneapolis, MNPHASE1198 participantsBayer

View Study Details

NCT05267626Recruiting

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

This is a first in human, open-label, multi-center Phase 1 / 2 study to evaluate the safety, tolerability, and initial efficacy of AU-007 in patients with advanced solid tumors. AU-007 will be adminis...

Minneapolis, MNPHASE1159 participantsAulos Bioscience, Inc.

View Study Details

NCT06449677Recruiting

Bionic Pancreas in CFRD

This multi-center randomized controlled trial (RCT) will compare efficacy and safety endpoints using the insulin-only configuration of the iLet Bionic Pancreas System (BP) versus a control group using...

Minneapolis, MNPHASE3150 participantsJaeb Center for Health Research

View Study Details

NCT06271512Recruiting

A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel

The main aim of this study is to collect real-world longitudinal data on participants with β-thalassemia treated with betibeglogene autotemcel (beti-cel) in the post marketing setting. To assess the l...

Minneapolis, MN150 participantsGenetix Biotherapeutics Inc.

View Study Details

NCT04486352Recruiting

A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer

This is a Phase IB/II multi-cohort study designed to evaluate the efficacy and safety of targeted agents with or without cancer immune checkpoint therapy with atezolizumab in participant with recurren...

Minneapolis, MNPHASE1148 participantsAlliance Foundation Trials, LLC.

View Study Details

NCT07061574Recruiting

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

This multi-center randomized controlled trial will assess the safety and efficacy of ATG followed by either adalimumab or verapamil in preserving insulin secretion 2 years from randomization in person...

Minneapolis, MNPHASE1120 participantsCity of Hope Medical Center

View Study Details

NCT05456321Recruiting

CIFASD 5 tDCS and Cognitive Training

This is a randomized placebo-controlled trial of cognitive training with transcranial direct current stimulation (tDCS) for children and adolescents (ages 8 - 17 years) with prenatal alcohol exposure ...

Minneapolis, MNNA70 participantsUniversity of Minnesota

View Study Details

NCT05467150Recruiting

Maternal Probiotic Supplementation for Improved Outcomes in Infants of Diabetic Mothers

The purpose of this study is to test the hypothesis that maternal probiotic supplementation is associated with infant gut microbiome variation and improved neurodevelopmental outcomes as measured by E...

Minneapolis, MNNA60 participantsUniversity of Minnesota

View Study Details

NCT07140900Recruiting

Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer

The main objective of the trial is to evaluate the safety and tolerability of xaluritamig in combination with darolutamide or abiraterone....

Minneapolis, MNPHASE160 participantsAmgen

View Study Details

NCT07090122Recruiting

Radiofrequency Ablation/Bone Augmentation + Radiotherapy vs Radiotherapy Alone

This is a single-center, randomized controlled pilot study of radiofrequency ablation and bone augmentation (RFA/BA) plus radiotherapy (RT) vs. RT alone in patients with metastatic T5-L5 disease of th...

Minneapolis, MNNA36 participantsUniversity of Minnesota

View Study Details

NCT03984643Recruiting

Algorithms for Programming DBS Systems for ET

Deep brain stimulation (DBS) targeting the Vim thalamus (ventralis intermedius nucleus) is an FDA-approved neuromodulation therapy for treating postural and action tremor in individuals with essential...

Minneapolis, MNNA25 participantsUniversity of Minnesota

View Study Details

NCT05897775Recruiting

Coordinated Reset Deep Brain Stimulation for Essential Tremor

Deep brain stimulation (DBS) is a surgical procedure for the treatment of Essential Tremor (ET). A novel approach to current DBS approaches is called coordinated reset DBS (CR-DBS) which uses differen...

Minneapolis, MNPHASE123 participantsUniversity of Minnesota

View Study Details

NCT05338658Recruiting

Study of PAT in Patients With Solid Tumor Cancers

This is a single center Phase I study with extension of peptide alarm therapy (PAT) administered by intratumoral (IT) injection during the 1st course of a standard of care intravenous PD-1/PD-L1 inhib...

Minneapolis, MNPHASE121 participantsMasonic Cancer Center, University of Minnesota

View Study Details

NCT06771206Recruiting

Evaluation of Accuracy of the Owlet OSS 3.0 Sensor in the Neonatal Population

The sponsor of this study, Owlet Baby Care, Inc., is comparing the accuracy of their pulse oximeter Sensor with the measurements of oxygen levels in newborns who are already being monitored with arter...

Minneapolis, MNNA20 participantsOwlet Baby Care, Inc.

View Study Details

About Essential Tremor Clinical Trials in Minneapolis

Essential tremor is one of the most common movement disorders, causing involuntary shaking, most often in the hands. It is different from Parkinson's disease, though the two can be confused. Treatment includes medications, focused ultrasound, and deep brain stimulation for severe cases.

There are currently 20 essential tremor clinical trials recruiting participants in Minneapolis, MN. These studies are seeking a combined 79,454 participants. Research is being sponsored by University of South Florida, Children's Hospital Medical Center, Cincinnati, Vivace Therapeutics, Inc and 12 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Essential Tremor Clinical Trials in Minneapolis — FAQ

Are there essential tremor clinical trials in Minneapolis?

Yes, there are 20 essential tremor clinical trials currently recruiting in Minneapolis, MN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Minneapolis?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Minneapolis research site will contact you about next steps.

Are clinical trials in Minneapolis free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Minneapolis studies also compensate for your time and travel.

What essential tremor treatments are being tested?

The 20 active trials in Minneapolis are testing new therapies including novel drugs, biologics, and treatment approaches for essential tremor.

Data updated July 18, 2026 from ClinicalTrials.gov